In diagnostic manufacturing, speed and cost pressures often tempt manufacturers to cut corners on antibody selection. However, using unvalidated antibody pairs, especially in Lateral Flow Assays (LFAs) for targets like Dengue NS1…
Importance of antibody pair validation in LFA development Rapid diagnostic tests, especially lateral flow immunoassays (LFIAs) are critical for early detection of viruses like Dengue NS1 and HBsAg, particularly in resource-limited settings. But…
Envelope proteins are viral glycoproteins embedded in the outer membrane of enveloped viruses like coronavirus, influenza, HIV, and HCV. Such proteins like spike (S), envelope (E), and membrane (M) mediate…
Understanding TNF-α in Diagnostics Tumor Necrosis Factor-alpha (TNF-α) is a central cytokine in inflammation and immune signaling. Dysregulated TNF-α levels are implicated in autoimmune diseases such as rheumatoid arthritis, psoriasis,…
In diagnostic assay development, sensitivity is everything. Whether you are working on infectious disease screening, biomarker detection, or therapeutic monitoring, the ability to detect analytes at ultra-low concentrations can make…
This is how 'Native CRP Protein' and 'HBsAg Ad/Ay Antigens' are powering diagnostics Introduction In the diagnostic landscape, precision starts with high-quality reagents. Two critical components, C-reactive protein (CRP) for inflammation…
Why ADA Detection? Biologic therapies such as etanercept (a TNF-α inhibitor widely prescribed for autoimmune diseases like rheumatoid arthritis, ankylosing spondylitis, and psoriasis) have transformed patient outcomes. However, one major challenge limits…
Scaling from the lab bench to full-scale manufacturing is one of the most exciting and most challenging stages for diagnostic developers. You have validated your assay in R&D, the results…
In the fast-paced world of in-vitro diagnostics (IVD), access to biologically relevant and functionally validated proteins can make or break assay performance. At Denovo Biolabs, we recognize this need and supply researchers and…
With rising global incidence of autoimmune conditions and biologic therapeutics, demand for cytokine-based diagnostics is accelerating. Recombinant TNF alpha sits at the center of this transformation. Enabling faster, more reliable diagnostics and therapeutic…
Therapeutic antibodies like Nivolumab have revolutionized cancer care, offering new hope to patients across the globe. However, the success of these therapies heavily depends on accurate pharmacokinetic (PK) monitoring and that…
Dengue remains a pressing global health challenge, especially in tropical and subtropical regions like India, Southeast Asia, and South America. With rising caseloads and overlapping symptoms with Zika, Chikungunya and…
